Zyrtec Reps' Violative Statements Established By Survey Data, Judge Says
Executive Summary
Physician survey data is sufficient to establish violative statements made by Pfizer's Zyrtec sales reps, New York City federal court Judge Lawrence McKenna said in granting a May 23 preliminary injunction sought by Schering-Plough, which markets the competing antihistamine Claritin.